Futura Medtech has announced a strategic investment in Bengaluru-based Rivarp Medical, expanding its medtech platform to include devices and implants for orthopedics, neurosurgery, and interventional cardiology.
This investment is part of Jashvik Capital's broader strategy to develop a diverse medical device business with both domestic and international reach. Rivarp Medical, established in 2016, has created a robust product portfolio and has gained significant regulatory approvals, including EU MDR and US FDA certifications, which enhance its market presence. The company operates through a network of over 100 channel partners, distributing its products across India and globally.
According to Naresh Patwari, founder of Jashvik Capital, the medical devices sector presents substantial growth opportunities. The acquisition aims to leverage synergies in innovation, manufacturing, and distribution. MT Naidu, founder of Rivarp, emphasized that the partnership will facilitate access to capital for innovation and enhance customer engagement through Futura's extensive distribution channels.
This strategic move indicates a growing trend in the medtech industry where companies are consolidating resources to enhance innovation and market reach, particularly in rapidly expanding sectors such as medical devices.